Curet Myriam, Director at NEKTAR THERAPEUTICS (NKTR), sold 1,560 shares at $17.82 ($28K) on 2020-12-15, disclosed to the SEC on 2020-12-17.
Scheduled sale ($28k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ISRG | SELL | 2021-02-17 | $4.4M | — | Filing → |
| ISRG | SELL | 2020-10-21 | $644K | — | Filing → |
| ISRG | SELL | 2020-07-27 | $1.2M | — | Filing → |